{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T01:22:29Z","timestamp":1794792149454,"version":"4.9.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["25SF1907000"],"award-info":[{"award-number":["25SF1907000"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014219","name":"National Science Fund for Distinguished Young Scholars","doi-asserted-by":"publisher","award":["82425015"],"award-info":[{"award-number":["82425015"]}],"id":[{"id":"10.13039\/501100014219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2023698"],"award-info":[{"award-number":["BE2023698"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012462","name":"Collaborative Innovation Center of Suzhou Nano Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012462","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20254Z0019"],"award-info":[{"award-number":["20254Z0019"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018558","name":"Shanghai Shuguang Program","doi-asserted-by":"publisher","award":["24SG11"],"award-info":[{"award-number":["24SG11"]}],"id":[{"id":"10.13039\/501100018558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171102"],"award-info":[{"award-number":["82171102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2321005"],"award-info":[{"award-number":["T2321005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32530060"],"award-info":[{"award-number":["32530060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFA0915000"],"award-info":[{"award-number":["2023YFA0915000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fund for the Development of Science and Technology","doi-asserted-by":"publisher","award":["FDCT 0002\/2022\/AKP"],"award-info":[{"award-number":["FDCT 0002\/2022\/AKP"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.medj.2026.101298","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:49:18Z","timestamp":1789742958000},"page":"101298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mucoadhesive recombinant human catalase for dry eye disease: From protein engineering to first-in-human study"],"prefix":"10.1016","volume":"7","author":[{"given":"Ming","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiteng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihua","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jini","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2026.101298_bib1","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1056\/NEJMra1407936","article-title":"Dry Eye","volume":"378","author":"Clayton","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2026.101298_bib2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jama.2021.19963","article-title":"Dry Eye Disease: An Update in 2022","volume":"327","author":"Hakim","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2026.101298_bib3","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.3390\/ijms23052434","article-title":"Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease","volume":"23","author":"Labetoulle","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.medj.2026.101298_bib4","first-page":"CD009729","article-title":"Over the counter (OTC) artificial tear drops for dry eye syndrome","volume":"2","author":"Pucker","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.medj.2026.101298_bib5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2015.07.007","article-title":"Dexamethasone nanowafer as an effective therapy for dry eye disease","volume":"213","author":"Coursey","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.medj.2026.101298_bib6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/ICO.0b013e31823f8c9b","article-title":"Clinical Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops","volume":"31","author":"Moscovici","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.medj.2026.101298_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.clae.2017.09.013","article-title":"Tear lipid supplement prophylaxis against dry eye in adverse environments","volume":"41","author":"Gokul","year":"2018","journal-title":"Cont. Lens Anterior Eye."},{"key":"10.1016\/j.medj.2026.101298_bib8","first-page":"41","article-title":"Efficacy of Perfluorohexyloctane for the Treatment of Patients with Dry Eye Disease: A Meta-Analysis","volume":"68","author":"Taloni","year":"2025","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.medj.2026.101298_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/ojo.OJO_29_2017","article-title":"Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes","volume":"11","author":"Shrivastava","year":"2018","journal-title":"Oman J. Ophthalmol."},{"key":"10.1016\/j.medj.2026.101298_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s12325-012-0033-9","article-title":"Diquafosol Ophthalmic Solution for Dry Eye Treatment","volume":"29","author":"Nakamura","year":"2012","journal-title":"Adv. Ther."},{"key":"10.1016\/j.medj.2026.101298_bib11","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s40265-017-0834-x","article-title":"Ciclosporin Ophthalmic Emulsion 0.1%: A Review in Severe Dry Eye Disease","volume":"77","author":"Hoy","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.medj.2026.101298_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1167\/tvst.7.5.24","article-title":"Once-Daily Cyclosporine-A-MiDROPS for Treatment of Dry Eye Disease","volume":"7","author":"Coursey","year":"2018","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.medj.2026.101298_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/17512433.2025.2543380","article-title":"Current and emerging pharmacological treatment options for patients with dry eye disease","volume":"18","author":"Cukurova","year":"2025","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.medj.2026.101298_bib14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jtos.2019.02.012","article-title":"Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: A systematic literature review","volume":"17","author":"Holland","year":"2019","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.medj.2026.101298_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/pharmaceutics13020207","article-title":"Formulation Considerations for the Management of Dry Eye Disease","volume":"13","author":"Agarwal","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.medj.2026.101298_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.medj.2026.101298_bib17","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1111\/aos.13526","article-title":"Dry eye disease and oxidative stress","volume":"96","author":"Seen","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.medj.2026.101298_bib18","article-title":"Dry Eye Disease: Oxidative Stress on Ocular Surface and Cutting-Edge Antioxidants","volume":"9","author":"Hu","year":"2025","journal-title":"Glob. Chall."},{"key":"10.1016\/j.medj.2026.101298_bib19","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1042\/CS20171246","article-title":"Oxidative stress and reactive oxygen species: a review of their role in ocular disease","volume":"131","author":"Ung","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.medj.2026.101298_bib20","doi-asserted-by":"crossref","first-page":"BIO151","DOI":"10.1167\/iovs.17-21436","article-title":"Oxidative Stress Measures of Lipid and DNA Damage in Human Tears","volume":"58","author":"Haworth","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.medj.2026.101298_bib21","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1097\/ICO.0b013e3181ae8689","article-title":"The Role of Oxidative Stress and Inflammation in Dry Eye Disease","volume":"28","author":"Dogru","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.medj.2026.101298_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/jop.2020.0087","article-title":"A Randomized Double-Masked Phase 2a Trial to Evaluate Activity and Safety of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in Dry Eye Disease","volume":"37","author":"Clark","year":"2021","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.medj.2026.101298_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100938","article-title":"Reproxalap Improves Ocular Redness, Tear Production, and Symptoms in a Pivotal Dry Eye Disease Chamber Trial","volume":"6","author":"Garg","year":"2026","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.medj.2026.101298_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/emm.1999.9","article-title":"Redox signaling: hydrogen peroxide as intracellular messenger","volume":"31","author":"Rhee","year":"1999","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.medj.2026.101298_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/ars.2006.8.243","article-title":"Hydrogen Peroxide: A Signaling Messenger","volume":"8","author":"Stone","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.medj.2026.101298_bib26","doi-asserted-by":"crossref","first-page":"8735","DOI":"10.1074\/jbc.R113.544635","article-title":"Role of Metabolic H2O2 Generation: Redox Signaling and Oxidative Stress","volume":"289","author":"Sies","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.medj.2026.101298_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pbiomolbio.2018.03.001","article-title":"Catalase and its mysteries","volume":"140","author":"Sepasi Tehrani","year":"2018","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.medj.2026.101298_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202415353","article-title":"Eye-Drop Nano-Formulation of Catalase Self-Assembled with Thiolated Chitosan for Effective Treatment of Dry Eye Disease","volume":"37","author":"Shao","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.medj.2026.101298_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202526658","article-title":"Sustained Ocular Antioxidant Therapy with Thiolated Catalase for Intervention of Corneal Injuries and Atopic Conjunctivitis","volume":"36","author":"Shao","year":"2026","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.medj.2026.101298_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1021\/bc00006a003","article-title":"Substituted 2-iminothiolanes: reagents for the preparation of disulfide cross-linked conjugates with increased stability","volume":"1","author":"Goff","year":"1990","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.medj.2026.101298_bib31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3390\/ijms18030509","article-title":"A Comparison of the Effects of Benzalkonium Chloride on Ocular Surfaces between C57BL\/6 and BALB\/c Mice","volume":"18","author":"Yang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.medj.2026.101298_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121463","article-title":"Rodent models for dry eye syndrome: Standardization using benzalkonium chloride and scopolamine hydrobromide","volume":"317","author":"Chaudhari","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.medj.2026.101298_bib33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/15569527.2017.1291664","article-title":"Sodium perbarate and benzalkonium chloride induce DNA damage in Chang conjunctival epithelial cells","volume":"36","author":"Zhang","year":"2017","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.medj.2026.101298_bib34","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jtos.2019.12.006","article-title":"Immune-Goblet cell interaction in the conjunctiva","volume":"18","author":"Alam","year":"2020","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.medj.2026.101298_bib35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","article-title":"Reactive Oxygen Species in Metabolic and Inflammatory Signaling","volume":"122","author":"Forrester","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.medj.2026.101298_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102756","article-title":"Pathophysiologic role of Interleukin-33\/ST2 in Sj\u00f6gren\u2019s syndrome","volume":"20","author":"Soyfoo","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.medj.2026.101298_bib37","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.3390\/ijms21093111","article-title":"Dry Eye Disease and Tear Cytokine Levels\u2014A Meta-Analysis","volume":"21","author":"Roda","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.medj.2026.101298_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jtos.2015.10.004","article-title":"The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye","volume":"14","author":"Lanza","year":"2016","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.medj.2026.101298_bib39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jamaophthalmol.2024.0101","article-title":"Water-Free Cyclosporine Ophthalmic Solution vs Vehicle for Dry Eye Disease: A Randomized Clinical Trial","volume":"142","author":"Peng","year":"2024","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.medj.2026.101298_bib40","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/ICO.0000000000002622","article-title":"A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease","volume":"40","author":"Tauber","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.medj.2026.101298_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109391","article-title":"Involvement of aberrant acinar cell proliferation in scopolamine-induced dry eye mice","volume":"227","author":"Chen","year":"2023","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.medj.2026.101298_bib42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.preteyeres.2012.02.003","article-title":"Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease","volume":"31","author":"Barabino","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.medj.2026.101298_bib43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40662-019-0137-2","article-title":"Dry eye disease immune responses and topical therapy","volume":"6","author":"McMonnies","year":"2019","journal-title":"Eye Vis. (Lond.)"},{"key":"10.1016\/j.medj.2026.101298_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aopr.2024.08.003","article-title":"The alterations of ocular surface metabolism and the related immunity inflammation in dry eye","volume":"5","author":"Wan","year":"2025","journal-title":"Adv. Ophthalmol. Pract. Res."},{"key":"10.1016\/j.medj.2026.101298_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-3768.2015.0251","article-title":"The Role of Antigen Presenting Cells in the Pathophysiology of Dry Eye","volume":"93","author":"Stern","year":"2015","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.medj.2026.101298_bib46","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10792-020-01329-0","article-title":"Antigen-presenting cells in ocular surface diseases","volume":"40","author":"Kalogeropoulos","year":"2020","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.medj.2026.101298_bib47","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41385-018-0127-z","article-title":"Age-associated antigen-presenting cell alterations promote dry-eye inducing Th1 cells","volume":"12","author":"Bian","year":"2019","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.medj.2026.101298_bib48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4049\/jimmunol.2300224","article-title":"Integrating T Cell Activation Signals to Regulate Gene Expression through Cyclosporin-Sensitive NFAT","volume":"211","author":"Kaye","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.medj.2026.101298_bib49","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1182\/blood.V124.21.2495.2495","article-title":"A Role for NFAT in Innate Immunity: Neutrophil Effector Functions in Patients after Allogeneic Hematopoietic Stem Cell Transplantation Under Cyclosporine \u0391 Treatment","volume":"124","author":"Plein","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.medj.2026.101298_bib50","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41551-020-00606-8","article-title":"Gelling hypotonic polymer solution for extended topical drug delivery to the eye","volume":"4","author":"Kim","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.medj.2026.101298_bib51","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.actbio.2022.01.044","article-title":"Alleviation of dry eye syndrome with one dose of antioxidant, anti-inflammatory, and mucoadhesive lysine-carbonized nanogels","volume":"141","author":"Lin","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.medj.2026.101298_bib52","doi-asserted-by":"crossref","first-page":"25118","DOI":"10.1021\/acsnano.3c07817","article-title":"Unveiling the Power of Gabapentin-Loaded Nanoceria with Multiple Therapeutic Capabilities for the Treatment of Dry Eye Disease","volume":"17","author":"Yang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.medj.2026.101298_bib53","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12951-024-02448-x","article-title":"Mucoadhesive, antioxidant, and lubricant catechol-functionalized poly(phosphobetaine) as biomaterial nanotherapeutics for treating ocular dryness","volume":"22","author":"Bui","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.medj.2026.101298_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/sstr.202570006","article-title":"Design of Highly Adhesive Urchin-Like Gold Nanostructures for Effective Topical Drug Administration and Symptomatic Relief of Corneal Dryness","volume":"6","author":"Ghosh","year":"2025","journal-title":"Small Struct."},{"key":"10.1016\/j.medj.2026.101298_bib55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ajo.2026.02.031","article-title":"Defining Discordance Between Signs and Symptoms in Dry Eye Disease: Insights from the Dry Eye Assessment and Management (DREAM) Study","volume":"286","author":"Matar","year":"2026","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.medj.2026.101298_bib56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtos.2017.10.001","article-title":"Neuropathic pain and dry eye","volume":"16","author":"Galor","year":"2018","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.medj.2026.101298_bib58","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12929-022-00821-2","article-title":"Interleukin-20 is involved in dry eye disease and is a potential therapeutic target","volume":"29","author":"Wang","year":"2022","journal-title":"J. Biomed. Sci."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634026003016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634026003016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T00:59:12Z","timestamp":1794790752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634026003016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2666634026003016"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2026.101298","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucoadhesive recombinant human catalase for dry eye disease: From protein engineering to first-in-human study","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2026.101298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101298"}}